President & CEO
Mr. Daly has over 23 years of experience in the medical device space. Over 14 years in sales, marketing, international marketing and leadership positions throughout the Johnson & Johnson organization including Ethicon Endo-Surgery, Ethicon Products, J&J Medical Australia/New Zealand, J&J Medical Asia Pacific and Cohera Medical, Inc.® Within Johnson & Johnson, he held positions of increasing responsibility in marketing, international marketing and sales. He successfully launched a surgical technology business in Australia and created and implemented the first-ever regulatory review of safety and efficacy of that new technology by the Australian Government. He continued his Johnson & Johnson entrepreneurial-like career track as a marketing leader in J&J Medical Asia Pacific by creating and implementing training and development programs in China, India, Korea, Singapore, and the Philippines. Mr. Daly started Cohera Medical in January 2006 and led four successful funding rounds of over $70M in capital from private investors to facilitate Cohera Medical’s two lead products; TissuGlu® Surgical Adhesive and Sylys® Surgical Sealant through the FDA approval process for medical devices. Prior to starting Cohera Medical and Johnson & Johnson, Mr. Daly spent over four years on active duty in the U.S. Army as a field artillery officer serving around the world. A native of New York, he is a graduate of the U.S. Military Academy at West Point where he received a B.S. in Engineering with a concentration in Latin American Studies. He played varsity lacrosse during his four years at West Point and was an All-American. Mr. Daly serves on several Boards, including the Advanced Medical Technology Association’s (AdvaMed) Board of Directors as well as the Emerging Growth Company Council (EGCC) for AdvaMed, the Pittsburgh Technology Council and Girls Hope Pittsburgh, a nonprofit that provides a well-balanced, nurturing home and quality education through college for academically capable girls. He is also a member of the Young Presidents Organization (YPO).
Dottie Clower, Ph.D.
Vice President of Research and Development/Chief Scientific Officer
Dr. Clower was instrumental in the early formation of Cohera Medical, Inc.® dating back to 2003 and led the development of Cohera Medical from its ideation to its successful seed financing. She currently leads Cohera Medical’s R&D efforts, and her team successfully brought the company’s lead product TissuGlu® Surgical Adhesive from laboratory prototype through human clinical trials. Prior to joining Cohera Medical, she specialized in commercializing early-stage technologies through her leadership position in the University of Pittsburgh’s Office of Enterprise Development. Dr. Clower is a neuroscientist and chemist with over twenty years of research experience in both industrial and academic environments. Her work has been published in Nature, Journal of Neuroscience, Journal of Neurophysiology, Cerebral Cortex and Plastic and Reconstructive Surgery. She also brings experience from Baxter Healthcare where she worked on the development of pre-mixed I.V. drug delivery systems within Baxter’s Pharmaceutical R&D Division. Dr. Clower holds a B.A. in Chemistry from Northwestern University in Chicago and a Ph.D. in Neuroscience from Emory University in Atlanta.
Chad Coberly, M.B.A., J.D.
Vice President of Clinical, Regulatory and Legal Affairs
Mr. Coberly has more than 20 years of experience in the medical device industry, primarily in the areas of regulatory/clinical affairs, compliance, quality systems, intellectual property, business development, litigation and general legal affairs. Prior to joining Cohera Medical, Inc.®, he served as the VP of Legal and Regulatory Affairs for Zassi Medical Evolutions, where he led the regulatory and legal aspects of the Worldwide commercialization and later the successful divestiture of a gastrointestinal catheter line. He brings intellectual property experience from the law firm of Howard and Howard, and the Surgical Group of the Stryker Corporation where he held regulatory and legal related positions. He has published articles in Food and Drug Law Institute publications and has held board-level positions with Medical Device Associations. Mr. Coberly holds a J.D. from Michigan State University and a bachelor’s degree in biomedical engineering from Tulane University. He also has completed M.B.A. studies at Boston University. He is admitted to practice before the U.S. Patent and Trademark Office and is a member of the Michigan Bar.
Vice President of Finance and CFO
Mr. Wonsettler has more than 20 years of financial management experience with emerging private and public companies. Prior to joining Cohera Medical, Inc.®, he was the CFO for Active Media/ClubCom, Inc., venture-capital- backed, start-up companies in Pittsburgh, PA for which he built the accounting and treasury departments. Prior to this, Mr. Wonsettler was the CFO and Treasurer for SMT Health Services, Inc. (SMT), a Wexford, PA based healthcare services provider. He was the head of SMT’s finance department when the company was owned by private equity firm Apollo Management L.P. He has also served as an independent financial consultant to early stage venture-capital backed companies and earlier in his career, he was an audit professional with KPMG L.L.P. In addition, Mr. Wonsettler has extensive mergers and acquisition experience and has been directly involved in completing numerous transactions. He is a Certified Public Accountant and a member of the Pennsylvania Institute of Certified Public Accountants (PICPA). He received a Bachelor’s degree of accounting from Washington and Jefferson College in Washington, PA.
Vice President, Europe
Mart Pearson has more than 20 years of experience in international sales and marketing of medical devices. He has been responsible for the introduction of new technologies and products in surgical oncology, minimally invasive surgery, endoscopy, orthopedics, spine surgery, general surgery and infection prevention. Most recently, he was Vice President, International, at Salient Surgical Technologies Inc. He led the introduction of the company’s saline-enhanced radiofrequency product platform to the European markets starting in 2001 and was responsible for all markets outside of the U.S. from 2005 through 2008. Prior to that, he was responsible for opening one of the first international subsidiaries of STERIS Corporation, where he successfully established the SYSTEM 1 low temperature liquid sterilization system as market leader in Italy. Mr. Pearson holds a bachelor’s degree in analytic philosophy from Pomona College and has continuously pursued his interests in new market development, entrepreneurial business, languages, cross cultural communications and management. He is located in Northern Italy.